FDA 483 - GCAM Inc - September 16, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of GCAM, Inc. in San Bernardino, CA, identified a critical failure in the informed consent process for plasmapheresis and tetanus immunization programs. Physician substitutes consistently neglected to verbally explain the associated risks and hazards to donors, despite the firm's own standard operating procedures requiring such disclosures. This lapse prevented donors from having a clear opportunity to refuse the procedures, indicating a significant compliance issue.
ID · 092a5e9d-3085-4177-b1d8-a079482f9384